Canton Nuleic Acids Forum

Speakers

	Howard CHANG, MD, PhD Professor, Stanford University, USA Howard Hughes Medical Institute			Muthiah MANOHARAN, PhD Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, USA Board Director, Oligonucleotide Therapeutics Society

	Stanley CROOKE, MD, PhD Founder, CEO and Chairman of the Board Ionis Pharmaceuticals, USA			Craig MELLO, PhD Professor, University of Massachusetts Howard Hughes Medical Institute, USA Nobel Prize in Physiology or Medicine (2006)

	Mark EDBROOKE, PhD Director, AstraZeneca, UK			Mikiko SIOMI, PhD Professor, the University of Tokyo, Japan

	Jan GORODKIN, PhD Professor, University of Copenhagen Director, Center for Non-Coding RNA in Technology and Health, Denmark			William SKARNES, PhD Senior Group Leader Wellcome Trust Sanger Institute, UK

	Chuan HE, PhD Professor, University of Chicago, USA Howard Hughes Medical Institute			Erik SONTHEIMER, PhD Professor, University of Massachusetts Medical School, USA

	Robert HOLT, PhD Professor, University of British Columbia, Canada			Jian-Sheng SUN, PhD, HDR Professor, Muséum National d’Histoire Naturelle MNHN-CNRS-INSERM, France

	Jin-Soo KIM, PhD Professor, Seoul National University Director, Institute for Basic Science, South Korea			Elizabeth TRAN, PhD Associate Professor Purdue University, USA

	Troels KOCH, PhD VP and Head of Research, RNA Therapeutics Roche, Denmark / Switzerland			Ada YONATH, PhD Professor, Weizmann Institute of Science, Israel Nobel Prize in Chemistry 2009

	Ekkehard LEBERER, PhD Professor, Senior Director, Sanofi, Germany Founding Director, COMPACT Consortium			Yi-Tao YU, PhD Professor, University of Rochester Medical Center School of Medicine and Dentistry, USA

	Judy LIEBERMAN, MD, PhD Professor, Program Chair, Harvard Medical School American Academy of Arts & Sciences, USA